Żarłok Kamil
Food and Pharma Consulting, Warszawa, ul. Batalionów Chłopskich 82a/44, 01-308 Warszawa +48 22 2521738
Wiad Lek. 2016;69(2 Pt 2):271-5.
Probiotics are an intensively growing part of the pharmaceutical and nutrition industries. Along with the intensive development of sales volumes and product offers, more and more scientific publications on this subject are available (at the time of writing this article there are available almost 14 thousand publications in PubMed library). Scientists are trying to find new uses and new sources for this crucial group of nutrients or potential drugs. At the beginning of the XXI century it was discovered that the source of probiotics doesn't need to be only gastrointestinal tract (as previously thought), since they were obtained from breast milk which for many years were considered to be sterile. Probiotics from breast milk are an interesting group which could find application in mastitis, immunity support, infection prevention, infant colics and oral health. Main representative of this group is a strain of lactic acid bacteria Lactobacillus fermentum CECT5716.
益生菌是制药和营养行业中发展迅速的一部分。随着销量和产品种类的迅猛发展，关于这一主题的科学出版物越来越多（在撰写本文时，PubMed数据库中已有近14000篇相关出版物）。科学家们正在努力为这一关键的营养成分或潜在药物群体寻找新用途和新来源。在21世纪初，人们发现益生菌的来源不必仅限于胃肠道（如之前所认为的那样），因为它们可以从多年来一直被认为是无菌的母乳中获取。母乳中的益生菌是一个有趣的群体，可应用于乳腺炎、免疫支持、感染预防、婴儿腹绞痛和口腔健康等方面。该群体的主要代表是发酵乳杆菌CECT5716菌株。
